Table 3.
Variables | Univariate analysis
|
Multivariate analysis
|
||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age | 1.042 | 0.659–1.648 | 0.860 | |||
Sex | 0.927 | 0.578–1.486 | 0.753 | |||
Tumor location | 0.820 | 0.502–1.340 | 0.429 | |||
Tumor differentiation | 1.130 | 0.786–1.625 | 0.509 | |||
Lymphovascular invasion | 0.807 | 0.499–1.305 | 0.383 | |||
T stage | 2.086 | 1.071–4.062 | 0.031* | 1.365 | 0.624–2.986 | 0.436 |
Regional lymph node metastasis | 2.683 | 1.680–4.284 | <0.001* | 3.012 | 1.746–5.197 | <0.001* |
Distant metastasis | 3.102 | 1.905–5.053 | <0.001* | 2.599 | 1.496–4.516 | 0.001* |
Tumor size | 1.529 | 0.970–2.411 | 0.067 | |||
High CRNDE-h expression | 2.906 | 1.794–4.709 | <0.001* | 2.173 | 1.282–3.684 | 0.004* |
Note:
P-values are statistically significant.
Abbreviations: CI, Confidence interval; HR, hazard ratio; lncRNA, long noncoding RNA; CRNDE-h, colorectal neoplasia differentially expressed – h; CRC, colorectal cancer.